146 related articles for article (PubMed ID: 1810189)
1. High-pressure liquid chromatography and microbiological assay of serum ofloxacin levels in adults receiving intravenous and oral therapy for skin infections.
Auten GM; Preheim LC; Sookpranee M; Bittner MJ; Sookpranee T; Vibhagool A
Antimicrob Agents Chemother; 1991 Dec; 35(12):2558-61. PubMed ID: 1810189
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin treatment of difficult infections of the skin and skin structure.
Gentry LO; Rodriguez-Gomez G
Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally.
Bitar N; Claes R; Van der Auwera P
Antimicrob Agents Chemother; 1989 Oct; 33(10):1686-90. PubMed ID: 2589841
[TBL] [Abstract][Full Text] [Related]
4. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
[TBL] [Abstract][Full Text] [Related]
6. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
Liam CK; Aziah AM; Lim KH; Wong CM
Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
[TBL] [Abstract][Full Text] [Related]
7. Therapy of serious skin and soft tissue infections with ofloxacin administered by intravenous and oral route.
Lentino JR; Augustinsky JB; Weber TM; Pachucki CT
Chemotherapy; 1991; 37(1):70-6. PubMed ID: 2013245
[TBL] [Abstract][Full Text] [Related]
8. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
Echols R; Weinstein MP; O'Keeffe B; Shah A; Heller AH
J Antimicrob Chemother; 1994 Jan; 33(1):111-8. PubMed ID: 8157551
[TBL] [Abstract][Full Text] [Related]
9. Treatment of posttraumatic osteitis with intravenous ofloxacin.
Seibold R; Betz A
Clin Ther; 1991; 13(4):457-9. PubMed ID: 1933996
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients.
Mouton Y; Leroy O; Beuscart C; Sivery B; Senneville E; Chidiac C; Beaucaire G; Vincent du Laurier M
J Antimicrob Chemother; 1990 Nov; 26 Suppl D():115-21. PubMed ID: 2286586
[TBL] [Abstract][Full Text] [Related]
11. Fleroxacin 400 mg once daily versus ofloxacin 400 mg twice daily in skin and soft tissue infections.
Drehobl M; Koenig L; Barker M; St Clair P; Maladorno D
Chemotherapy; 1997; 43(5):378-84. PubMed ID: 9309373
[TBL] [Abstract][Full Text] [Related]
12. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
Guibert J; Kitzis MD; Acar JF
Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.
Chin A; Okamoto MP; Gill MA; Sclar DA; Berne TV; Yellin AE; Heseltine PN; Appleman MD
Antimicrob Agents Chemother; 1990 Dec; 34(12):2354-7. PubMed ID: 2088189
[TBL] [Abstract][Full Text] [Related]
14. Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.
Guay DR; Opsahl JA; McMahon FG; Vargas R; Matzke GR; Flor S
Antimicrob Agents Chemother; 1992 Feb; 36(2):308-12. PubMed ID: 1605596
[TBL] [Abstract][Full Text] [Related]
15. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
Mertes PM; Jehl F; Burtin P; Dopff C; Pinelli G; Villemot JP; Monteil H; Dureux JB
Antimicrob Agents Chemother; 1992 Nov; 36(11):2493-6. PubMed ID: 1489193
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ofloxacin in broiler chicken.
Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
[TBL] [Abstract][Full Text] [Related]
17. Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases.
Pappalardo G; Bianchi A; Scire Scappuzzo G; Mirone M; Salomone S
Int J Clin Pharmacol Res; 1989; 9(3):229-32. PubMed ID: 2663738
[TBL] [Abstract][Full Text] [Related]
18. Levofloxacin pharmacokinetics in ESRD and removal by the cellulose acetate high performance-210 hemodialyzer.
Sowinski KM; Lucksiri A; Kays MB; Scott MK; Mueller BA; Hamburger RJ
Am J Kidney Dis; 2003 Aug; 42(2):342-9. PubMed ID: 12900817
[TBL] [Abstract][Full Text] [Related]
19. Oral ofloxacin therapy for lower respiratory tract infection.
Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
[TBL] [Abstract][Full Text] [Related]
20. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
Powers RD; Schwartz R; Snow RM; Yarbrough DR
Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
